🇺🇸 FDA
Patent

US 7070973

Butyrylcholinesterase variants and methods of use

granted A61KA61K38/00

Quick answer

US patent 7070973 (Butyrylcholinesterase variants and methods of use) held by BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA expires Mon Jun 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
Grant date
Tue Jul 04 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K38/00